Swiss National Bank’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.54M | Hold |
186,965
| – | – | ﹤0.01% | 1114 |
|
|
2025
Q4 | $6.51M | Buy |
186,965
+2,000
| +1% | +$157K | ﹤0.01% | 1205 |
|
|
2025
Q3 | $15.4M | Buy |
184,965
+3,600
| +2% | +$261K | 0.01% | 742 |
|
|
2025
Q2 | $13.3M | Sell |
181,365
-1,300
| -0.7% | -$94.3K | 0.01% | 784 |
|
|
2025
Q1 | $20.9M | Sell |
182,665
-2,300
| -1% | -$140K | 0.01% | 605 |
|
|
2024
Q4 | $9.32M | Buy |
184,965
+1,700
| +0.9% | +$89.1K | 0.01% | 982 |
|
|
2024
Q3 | $8.48M | Hold |
183,265
| – | – | 0.01% | 1023 |
|
|
2024
Q2 | $5.95M | Buy |
183,265
+10,300
| +6% | +$282K | ﹤0.01% | 1159 |
|
|
2024
Q1 | $4.36M | Buy |
172,965
+1,200
| +0.7% | +$28.4K | ﹤0.01% | 1376 |
|
|
2023
Q4 | $5.58M | Sell |
171,765
-18,000
| -9% | -$494K | ﹤0.01% | 1231 |
|
|
2023
Q3 | $5.17M | Buy |
189,765
+1,800
| +1% | +$52.1K | ﹤0.01% | 1252 |
|
|
2023
Q2 | $4.18M | Sell |
187,965
-21,200
| -10% | -$488K | ﹤0.01% | 1418 |
|
|
2023
Q1 | $4.53M | Sell |
209,165
-23,600
| -10% | -$517K | ﹤0.01% | 1338 |
|
|
2022
Q4 | $4.73M | Buy |
232,765
+6,000
| +3% | +$150K | ﹤0.01% | 1345 |
|
|
2022
Q3 | $5.81M | Buy |
226,765
+2,100
| +0.9% | +$56.2K | ﹤0.01% | 1187 |
|
|
2022
Q2 | $5.34M | Sell |
224,665
-34,700
| -13% | -$756K | ﹤0.01% | 1278 |
|
|
2022
Q1 | $5.84M | Buy |
259,365
+16,500
| +7% | +$351K | ﹤0.01% | 1355 |
|
|
2021
Q4 | $4.81M | Sell |
242,865
-2,835
| -1% | -$57.5K | ﹤0.01% | 1487 |
|
|
2021
Q3 | $4.83M | Hold |
245,700
| – | – | ﹤0.01% | 1489 |
|
|
2021
Q2 | $5.41M | Sell |
245,700
-6,500
| -3% | -$145K | ﹤0.01% | 1452 |
|
|
2021
Q1 | $6M | Buy |
252,200
+4,000
| +2% | +$107K | ﹤0.01% | 1340 |
|
|
2020
Q4 | $6.49M | Buy |
248,200
+1,400
| +0.6% | +$29.5K | ﹤0.01% | 1194 |
|
|
2020
Q3 | $4.3M | Buy |
246,800
+3,700
| +2% | +$59K | ﹤0.01% | 1266 |
|
|
2020
Q2 | $4.09M | Buy |
243,100
+43,600
| +22% | +$613K | ﹤0.01% | 1261 |
|
|
2020
Q1 | $2.37M | Buy |
199,500
+3,600
| +2% | +$44.6K | ﹤0.01% | 1351 |
|
|
2019
Q4 | $2.37M | Buy |
195,900
+2,000
| +1% | +$27.8K | ﹤0.01% | 1632 |
|
|
2019
Q3 | $2.74M | Buy |
193,900
+1,800
| +0.9% | +$22.1K | ﹤0.01% | 1476 |
|
|
2019
Q2 | $2.14M | Buy |
192,100
+2,700
| +1% | +$30.1K | ﹤0.01% | 1651 |
|
|
2019
Q1 | $2.22M | Buy |
189,400
+4,700
| +3% | +$58.4K | ﹤0.01% | 1599 |
|
|
2018
Q4 | $2.47M | Buy |
184,700
+5,800
| +3% | +$76.7K | ﹤0.01% | 1432 |
|
|
2018
Q3 | $2.51M | Hold |
178,900
| – | – | ﹤0.01% | 1572 |
|
|
2018
Q2 | $2.81M | Buy |
178,900
+30,600
| +21% | +$532K | ﹤0.01% | 1478 |
|
|
2018
Q1 | $2.44M | Buy |
148,300
+5,100
| +4% | +$94.5K | ﹤0.01% | 1508 |
|
|
2017
Q4 | $2.59M | Buy |
143,200
+4,500
| +3% | +$81.5K | ﹤0.01% | 1477 |
|
|
2017
Q3 | $2.68M | Hold |
138,700
| – | – | ﹤0.01% | 1424 |
|
|
2017
Q2 | $1.64M | Buy |
138,700
+10,500
| +8% | +$114K | ﹤0.01% | 1717 |
|
|
2017
Q1 | $1.41M | Hold |
128,200
| – | – | ﹤0.01% | 1802 |
|
|
2016
Q4 | $931K | Hold |
128,200
| – | – | ﹤0.01% | 2083 |
|
|
2016
Q3 | $833K | Hold |
128,200
| – | – | ﹤0.01% | 2088 |
|
|
2016
Q2 | $700K | Buy |
128,200
+17,700
| +16% | +$92.1K | ﹤0.01% | 2173 |
|
|
2016
Q1 | $500K | Buy |
110,500
+19,800
| +22% | +$77.1K | ﹤0.01% | 2307 |
|
|
2015
Q4 | $452K | Hold |
90,700
| – | – | ﹤0.01% | 2315 |
|
|
2015
Q3 | $341K | Buy |
90,700
+14,200
| +19% | +$72.1K | ﹤0.01% | 2353 |
|
|
2015
Q2 | $460K | Buy |
+76,500
| New | +$469K | ﹤0.01% | 2279 |
|
|
2013
Q4 | – | Sell |
-97,600
| Closed | -$155K | – | 2509 |
|
|
2013
Q3 | $155K | Hold |
97,600
| – | – | ﹤0.01% | 2404 |
|
|
2013
Q2 | $169K | Buy |
+97,600
| New | +$175K | ﹤0.01% | 2402 |
|
Other funds holding CORT
ISL
VPM
VCM
PA
